Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 14, 2022
Discovery & Translation

Codiak’s pan beta-coronavirus vaccine; plus CNS-penetrating AAV9 variants and more

BioCentury’s roundup of translational news
BioCentury | Jun 25, 2022
Discovery & Translation

Expanding the CAR T cell toolbox

Snapshots from the literature add to the growing picture of next-gen CAR T manipulations that could enhance multiple cancer therapies 
BioCentury | Sep 19, 2018
Distillery Techniques

Drug platforms

BioCentury | Jun 24, 2010
Distillery Therapeutics

Indication: Cancer

BioCentury | May 22, 2006
Strategy

Content meets conduit

BioCentury | May 22, 2006
Company News

deCode, Illumina deal

BioCentury | May 16, 2006
Company News

deCode, Illumina in diagnostic deal

BioCentury | Jan 23, 2006
Tools & Techniques

Wntdow on diabetes

Items per page:
1 - 9 of 9